Holen Sie sich die Stockscreener-App
3.63
6.92%
-0.27
Trisalus Life Sciences Inc Aktie (TLSI) Neueste Nachrichten
TriSalus Life Sciences (TLSI) regulatory chief sells 316 shares to cover stock-vesting taxes - Stock Titan
296 shares sold for taxes: TriSalus Life Sciences (TLSI) research chief's sale was not discretionary. - Stock Titan
A sale to cover vesting taxes, not a discretionary trade: TriSalus Life Sciences (TLSI) insider sells 325 shares. - Stock Titan
TriSalus Life Sciences Warrant (TLSIW) Eases 2.35% to $0.83 as Traders Watch the $0.79 Support ZoneVolatility Smirk - dars.gov.et
TriSalus Life Sciences Warrant (TLSIW) Trades Flat at $0.85 as Traders Eye a Narrow RangeHigh Yield Stocks - https://www.siam.in/
Postmarket Movers: IPDN, SDA, JAGX Lead After-Hours Gainers; BMEA, EPSM, PFSA Lead Losers - ChartMill
TriSalus Life Sciences Shares Rise After Receiving FDA Clearance for TriNav Advance - marketscreener.com
Crude Oil Gains 1%; Cintas Earnings Top Views - benzinga.com
Gap-Up and Gap-Down Stocks: Sept. 23, 2026 Session - ChartMill
Gap-Up and Gap-Down Stocks: Sept. 23, 2026 Session - ChartMill
H.C. Wainwright raises TriSalus stock price target on FDA approval - Investing.com
H.C. Wainwright raises TriSalus stock price target on FDA approval By Investing.com - Investing.com Nigeria
Why is TriSalus Life Sciences stock surging today? - Investing.com
Why Worthington Enterprises Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket - Benzinga
TriSalus Life shares surge 29% on FDA device clearance By Investing.com - Investing.com South Africa
These stocks are moving in today's after hours session - ChartMill
FDA clears a device for smaller blood vessels. TriSalus made it. - Stock Titan
Postmarket Movers: IPDN, SDA, JAGX Lead After-Hours Gainers; BMEA, EPSM, PFSA Lead Losers - ChartMill
This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
TriSalus Life Sciences (TLSI) Climbs 1.55% as Support Holds Above $4.99Wyckoff Distribution - vinanet.vn
TriSalus Life Sciences (TLSI) Climbs 1.55% as Support Holds Above $4.99Sentiment Divergence - siam.in
TriSalus Life Sciences (TLSI) Climbs 1.55% as Support Holds Above $4.99Fibonacci Time Zone - careplusvn.com
TriSalus Life Sciences (TLSI) Climbs 1.55% as Support Holds Above $4.99Blue Chip Entry Points - dars.gov.et
TriSalus Life Sciences to Participate in the H.C. Wainwright & Company 28th Annual Global Investment Conference - Business Wire
TriSalus Life Sciences to Participate in the H.C. Wainwright & Company 28th Annual Global Investment Conference - Yahoo Finance
TriSalus Life Sciences (TLSI) Slips 2% as Shares Test Key $4.59 Support LevelKey Reversal Day - dars.gov.et
TriSalus Life Sciences (TLSI) Slips 2% as Shares Test Key $4.59 Support LevelPrice Momentum Stocks - siam.in
TriSalus (TLSI) Results Review: The Bottom-Line Figure Trails Its Comparison in the Available Record; Share Response: Shares Move 3.04% Lower in the Latest SessionWeak Earnings Momentum - vinanet.vn
TriSalus (TLSI) Market: Falls 2.18% to $5.16 on the Day; Technical Setup: the Near-Term Reference Band Stretches From $4.90 to $5.42 on the DayETF NAV Deviation - vinanet.vn
TriSalus (TLSI) Latest: Finishes 1.90% Lower at $5.17 at the Close; Next Test: the Near-Term Reference Band Stretches From $4.91 to $5.43ETF Premium Discount - vinanet.vn
TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates - Eastern Progress
TriSalus (TLSI) Latest Quarter: The Bottom-Line Figure Trails Its Comparison for This Review; Price Move: Shares Finish 2.47% Up in the Current UpdateSegment Revenue Breakdown - vinanet.vn
TriSalus Highlights Tumor-Treatment Expansion, FDA Catalyst at Growth Conference - MarketBeat
TriSalus Life Sciences (NASDAQ:TLSI) Cut to "Sell" at Wall Street Zen - MarketBeat
TriSalus Life Sciences Warrant (TLSIW) Plunges 55%: Critical Support Test at $0.53AAII Bullish - vinanet.vn
TriSalus Life Sciences Warrant (TLSIW) Plunges 55%: Critical Support Test at $0.53Put Call Ratio - dars.gov.et
TriSalus Life Sciences Warrant (TLSIW) Plunges 55%: Critical Support Test at $0.53Overnight Profile - dars.gov.et
TriSalus Life Sciences Warrant (TLSIW) Plunges 55%: Critical Support Test at $0.53Fund Manager Survey - careplusvn.com
CCORF Maintains TriSalus Life Sciences(TLSI.US) With Buy Rating, Maintains Target Price $7 - Moomoo
Trisalus Life Sciences at Canaccord Genuity: growth bets build By Investing.com - Investing.com Nigeria
Trisalus Life Sciences at Canaccord Genuity: growth bets build - Investing.com
TriSalus Life Sciences (TLSI) Advances 2.87% as Shares Hold Above $5.45 SupportETH Profile - dars.gov.et
Maxim Group Maintains TriSalus Life Sciences(TLSI.US) With Buy Rating, Raises Target Price to $14 - Moomoo
TriSalus Life Sciences (TLSI) Advances 2.96% to $5.75 as Biotech Momentum BuildsMA Cross Alert - careplusvn.com
TLSI Q2 2026 Earnings: EPS Misses Slightly as Liver-Tumor Focus ContinuesEarnings Revision Downgrade - careplusvn.com
TLSI Q2 2026 Earnings: EPS Misses Slightly as Liver-Tumor Focus ContinuesRetail Earnings Report - vinanet.vn
TriSalus Life Sciences (TLSI) Dips 4.3% to $5.37 as Shares Approach Key Support ZonePut Spread Alert - vinanet.vn
TriSalus Life Sciences earnings missed by $0.01, revenue topped estimates - Investing.com Canada
TriSalus Life Sciences (TLSI) Stock Surges As Losses Deepen Behind Strong Margins - Sahm
TriSalus Life Sciences (TLSI) Stock Surges As Losses Deepen Behind Strong Margins - simplywall.st
2.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):